LAUSR

Chronic Obstructive Pulmonary Disease (COPD) is a life-threatening lung disease and a major cause of morbidity and mortality worldwide. Although a curative therapy has yet to be found, permanent monitoring of biomarkers that reflect the disease progression plays a pivotal role for the effective management of COPD. The accurate examination of respiratory tract fluids like saliva is a promising approach for staging disease and predicting its upcoming exacerbations in a Point-of-Care (PoC) environment. However, the concurrent consideration of patients’ demographic and medical parameters is necessary for achieving accurate outcomes. Therefore, Machine Learning (ML) tools can play an important role for analyzing patient data and providing comprehensive results for the recognition of COPD in a PoC setting. As a result, the objective of this research work was to implement ML tools on data acquired from characterizing saliva samples of COPD patients and healthy controls as well as their demographic information for PoC recognition of the disease. For this purpose, a permittivity biosensor was used to characterize dielectric properties of saliva samples and, subsequently, ML tools were applied on the acquired data for classification. The XGBoost gradient boosting algorithm provided a high classification accuracy and sensitivity of 91.25% and 100%, respectively, making it a promising model for COPD evaluation. Integration of this model on a neuromorphic chip, in the future, will enable the real-time assessment of COPD in PoC, with low cost, low energy consumption, and high patient privacy. In addition, constant monitoring of COPD in a near-patient setup will enable the better management of the disease exacerbations.